Similar articles

• Low-molecular weight immunomodulators produced by microorganisms.

  Umezawa H. Umezawa H. Biotechnol Bioeng. 1980;22 Suppl 1:99-110. Biotechnol Bioeng. 1980. PMID: 6968594 No abstract available.
• Low-molecular-weight immunomodifiers produced by micro-organisms.

  Umezawa H. Umezawa H. Biotechnol Genet Eng Rev. 1985;3:255-73. doi: 10.1080/02648725.1985.10647815. Biotechnol Genet Eng Rev. 1985. PMID: 2936359 Review. No abstract available.
• Suppression of splenic enzyme activities by administration of aminopeptidase N (CD13) inhibitors: relationship between actions in vivo and in vitro.

  Kocha T, Ohtsuka E, Funahashi T, Fukuda T, Aoyagi T, Wanda T, Takeuchi T. Kocha T, et al. J Enzyme Inhib. 1994;8(3):187-95. doi: 10.3109/14756369409020200. J Enzyme Inhib. 1994. PMID: 7539487
• Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.

  Fibach E, Treves A, Kidron M, Mayer M. Fibach E, et al. J Cell Physiol. 1985 May;123(2):228-34. doi: 10.1002/jcp.1041230212. J Cell Physiol. 1985. PMID: 3884635
• Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.

  Umezawa H. Umezawa H. Rev Infect Dis. 1984 May-Jun;6(3):412-20. doi: 10.1093/clinids/6.3.412. Rev Infect Dis. 1984. PMID: 6234644 Review.